• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 144 filed by Alphatec Holdings Inc.

    6/11/25 11:15:31 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care
    Get the next $ATEC alert in real time by email
    Form 144 Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    Form 144

    NOTICE OF PROPOSED SALE OF SECURITIES
    PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933

    FORM 144

    144: Filer Information

    Filer CIK
    0001188264
    Filer CCC
    XXXXXXXX
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST

    Submission Contact Information

    Name
    Phone
    E-Mail Address

    144: Issuer Information

    Name of Issuer
    Alphatec Holdings, Inc.
    SEC File Number
    000-52024
    Address of Issuer
    5818 EL CAMINO REAL
    CARLSBAD
    CALIFORNIA
    92008
    Phone
    760-431-9286
    Name of Person for Whose Account the Securities are To Be Sold
    MCGINNIS KAREN K
    See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

    Relationship to Issuer
    Director

    144: Securities Information

    Title of the Class of Securities To Be SoldName and Address of the BrokerNumber of Shares or Other Units To Be SoldAggregate Market ValueNumber of Shares or Other Units OutstandingApproximate Date of SaleName the Securities Exchange
    COMMON
    THE CHARLES SCHWAB CORPORATION
    3000 Schwab Way
    Westlake � TX � 76262
    396348001.0014617270306/11/2025
    NASDAQ


    Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

    144: Securities To Be Sold

    Title of the ClassDate you AcquiredNature of Acquisition TransactionName of Person from Whom AcquiredIs this a Gift?Date Donor AcquiredAmount of Securities AcquiredDate of PaymentNature of Payment *
    COMMON06/16/2021VESTING RSU'sISSUERCheckbox not checked396306/16/2021N/A

    * If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



    Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

    144: Securities Sold During The Past 3 Months

    Nothing to ReportCheckbox checked

    144: Remarks and Signature

    Remarks
    FULL ACCOUNT TITLE: R MCGINNIS & K MCGINNIS TTEE, MCGINNIS FAMILY TRUST.
    Date of Notice
    06/11/2025
    Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1
    12/02/2024

    ATTENTION:

    The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
    Signature
    KAREN K. MCGINNIS

    ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

    Get the next $ATEC alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATEC

    DatePrice TargetRatingAnalyst
    6/16/2025$18.00Buy
    Lake Street
    8/1/2024Overweight → Equal-Weight
    Morgan Stanley
    7/8/2024$19.00Overweight
    Barclays
    2/9/2024$26.00Overweight
    Wells Fargo
    12/19/2023$16.00 → $18.00Buy
    Needham
    10/20/2023$22.00Buy
    ROTH MKM
    10/12/2022$12.00Buy
    Jefferies
    9/12/2022$13.00Overweight
    Morgan Stanley
    More analyst ratings

    $ATEC
    SEC Filings

    View All

    SEC Form 144 filed by Alphatec Holdings Inc.

    144 - Alphatec Holdings, Inc. (0001350653) (Subject)

    8/4/25 4:22:30 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Alphatec Holdings Inc.

    10-Q - Alphatec Holdings, Inc. (0001350653) (Filer)

    7/31/25 4:51:35 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Alphatec Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Alphatec Holdings, Inc. (0001350653) (Filer)

    7/31/25 4:19:03 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    ATEC to Participate in Upcoming Conferences

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that management will participate in the following investor conferences: The 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 12, 2025. The RBCCM Medical Supplies & Devices Virtual Symposium virtually on August 18, 2025, from 10:00am – 11:00am ET. The Piper Sandler MedTech and Diagnostics West Coast Bus Tour at The Ritz Carlton Laguna Niguel in Dana Point, CA at 7:55am PT. The Wells Fargo 2025 Healthcare Conference beginning on September 3, 2025, at The Encore Boston Harbor in Everett, MA, with a fireside c

    8/8/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC Reports Second Quarter 2025 Financial Results and Raises Full-Year Guidance

    Surgical revenue grew 29% to $168 million Total revenue grew $40 million or 27.5% Full-year revenue and profitability guidance increased Alphatec Holdings, Inc. (NASDAQ:ATEC), a spine-focused provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced financial results for the quarter ended June 30, 2025, and recent corporate highlights. Second Quarter 2025 Financial Results   Quarter Ended June 30, 2025 Total revenue $186 million GAAP gross margin 70% Non-GAAP gross margin 70% GAAP operating expenses $142 million Non-GAAP operating expenses $122 milli

    7/31/25 4:05:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

    7/17/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CHIEF OPERATING OFFICER Lish Scott sold $148,832 worth of shares (9,302 units at $16.00), decreasing direct ownership by 1% to 665,030 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/15/25 5:42:21 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    CEO Miles Patrick gifted 10,000 shares, decreasing direct ownership by 0.17% to 5,864,078 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/14/25 6:20:24 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    EVP, SALES Sponsel David covered exercise/tax liability with 982 shares, decreasing direct ownership by 0.15% to 671,861 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/7/25 7:04:15 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Leadership Updates

    Live Leadership Updates

    View All

    Paragon 28 Appoints Dave Demski to Board of Directors

    Paragon 28, Inc. (NYSE:FNA), (the "Company") a leader in foot and ankle surgical solutions, today announced the appointment of Dave Demski to serve as an independent director of the Company, effective immediately. Mr. Demski brings a wealth of global orthopedic expertise, with over two decades of executive leadership experience. With the addition of Mr. Demski, the Company increased the size of its Board of Directors from eight members to nine members and has further strengthened its strategic oversight and governance capabilities. Mr. Demski most recently served as the President and CEO of Globus Medical from August 2017 to April 2022, guiding the organization through a period of signifi

    12/11/24 9:00:00 AM ET
    $ATEC
    $FNA
    Medical/Dental Instruments
    Health Care

    Spineology® Appoints new Member to Leadership Team; Spine Veteran Emory Rooney joins as Executive Vice President of Sales

    Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today the addition of Emory Rooney as Executive Vice President, Sales. In this role, Rooney will lead U.S. market growth and sales efforts. Rooney comes to Spineology with extensive spine sales experience, having served in Medical Device fields related to spinal implants and navigation for nearly 20 years. "The addition of Emory adds even further conviction about our clear opportunity for growth at Spineology," said Brian Snider, Chief Executive Officer at Spineology. "I have had the opportunity to work with Emory and have seen his impact leading sales teams, building new terri

    4/4/24 9:05:00 AM ET
    $ATEC
    $SYK
    Medical/Dental Instruments
    Health Care

    John Booth to Retire as CEO of Spineology Inc.

    Brian Snider Appointed New CEO Spineology Inc. ("Spineology" or the "Company"), the leader in ultra-minimally invasive spine surgery, announced today that John Booth will retire from his role as Chief Executive Officer of Spineology, effective November 10, 2023. The Board of Directors has selected Brian Snider as its next Chief Executive Officer, effective November 13, 2023. Mr. Booth will remain with Spineology through 2024, serving in an advisory role to facilitate a smooth transition. Mr. Booth will also resign from the Board of Directors, and the Board has nominated Mr. Snider as a Director. Snider joins Spineology with nearly twenty years of progressive leadership experience in the

    11/9/23 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Lake Street resumed coverage on Alphatec with a new price target

    Lake Street resumed coverage of Alphatec with a rating of Buy and set a new price target of $18.00

    6/16/25 8:53:19 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Alphatec downgraded by Morgan Stanley

    Morgan Stanley downgraded Alphatec from Overweight to Equal-Weight

    8/1/24 3:06:35 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Barclays initiated coverage on Alphatec with a new price target

    Barclays initiated coverage of Alphatec with a rating of Overweight and set a new price target of $19.00

    7/8/24 7:34:11 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Bakst Evan bought $201,600 worth of shares (35,000 units at $5.76) (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:32:07 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Pelizzon David R bought $149,998 worth of shares (25,796 units at $5.81), increasing direct ownership by 8% to 331,696 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/26/24 4:27:25 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Director Demski David M bought $283,500 worth of shares (50,000 units at $5.67), increasing direct ownership by 21% to 288,441 units (SEC Form 4)

    4 - Alphatec Holdings, Inc. (0001350653) (Issuer)

    8/21/24 10:00:00 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    $ATEC
    Financials

    Live finance-specific insights

    View All

    $ATEC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    ATEC to Report Second Quarter 2025 Financial Results on July 31, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report second quarter 2025 financial results on July 31, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months.

    7/17/25 9:05:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report First Quarter 2025 Financial Results on May 1, 2025

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report first quarter 2025 financial results on May 1, 2025, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-In To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Inducemen

    4/14/25 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    ATEC to Report Third Quarter Financial Results on October 30, 2024

    Alphatec Holdings, Inc. (NASDAQ:ATEC), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, announced today that it will report third quarter 2024 financial results on October 30, 2024, after the market close. The Company will host a live webcast that day at 1:30 p.m. PT / 4:30 p.m. ET. Webcast To access the live webcast, please visit the Investor Relations Section of ATEC's Corporate Website. Dial-in To dial into the live webcast, please register at this link. Access details will be shared via email. Replay A replay of the webcast will remain available through the Investor Relations Section of ATEC's Corporate Website for twelve months. Indu

    10/7/24 9:00:00 AM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13D/A filed by Alphatec Holdings Inc.

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    11/12/24 8:04:57 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    3/22/24 7:57:56 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13D/A filed by Alphatec Holdings Inc. (Amendment)

    SC 13D/A - Alphatec Holdings, Inc. (0001350653) (Subject)

    5/12/23 4:51:18 PM ET
    $ATEC
    Medical/Dental Instruments
    Health Care